{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:19Z","timestamp":1792644019384,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119302","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:11:49Z","timestamp":1788448309000},"page":"119302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical evaluation of 68Ga-labelled Pt(IV)-DFO complexes as PET-imaging agents for osteosarcoma"],"prefix":"10.1016","volume":"320","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9057-6047","authenticated-orcid":false,"given":"Ines","family":"Lopez-Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4316-3701","authenticated-orcid":false,"given":"Lena","family":"Zachhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5897-7409","authenticated-orcid":false,"given":"Daniela","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Laskaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6656-1088","authenticated-orcid":false,"given":"Maximilian","family":"Krisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Patronas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-9623","authenticated-orcid":false,"given":"Diego","family":"Montagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-1434","authenticated-orcid":false,"given":"Claudia","family":"Kuntner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0404-4452","authenticated-orcid":false,"given":"Thomas","family":"Wanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119302_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/annonc\/mdy310","article-title":"Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2026.119302_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.9-4-422","article-title":"Biology and therapeutic advances for pediatric Osteosarcoma","volume":"9","author":"Marina","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ejmech.2026.119302_bib3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2026.119302_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ph18040520","article-title":"Advancements in osteosarcoma therapy: overcoming chemotherapy resistance and exploring novel pharmacological strategies","volume":"18","author":"Zhra","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119302_bib5","series-title":"Bone Sarcomas and Bone Metastases - from Bench to Bedside","author":"Heymann","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119302_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119302_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119302_bib8","doi-asserted-by":"crossref","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119302_bib9","doi-asserted-by":"crossref","DOI":"10.1021\/jm070280u","article-title":"Basis for design and development of platinum(IV) anticancer complexes","volume":"50","author":"Hall","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinorgbio.2018.11.008","article-title":"Multi-action Pt(IV) anticancer agents; do we understand how they work?","volume":"191","author":"Gibson","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119302_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29153453","article-title":"Recent advances on Pt-Based compounds for theranostic applications","volume":"29","author":"Ferrari","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119302_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1039\/D5DT02352A","article-title":"68Ga radiolabeling strategies in Pt(iv)-deferoxamine scaffolds for potential theranostic application","volume":"55","author":"Ferrari","year":"2026","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2026.119302_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00775-014-1214-6","article-title":"Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application","volume":"20","author":"Theiner","year":"2025","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib14","article-title":"Preclinical PET and SPECT imaging in small animals: technologies, challenges and translational impact","volume":"15","author":"Bruzgo-Grzybko","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119302_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1039\/D0JA00404A","article-title":"Application of ICP-MS to the development of metal-based drugs and diagnostic agents: where do we stand?","volume":"36","author":"Timerbaev","year":"2021","journal-title":"J. Anal. At. Spectrom."},{"key":"10.1016\/j.ejmech.2026.119302_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(99)00059-9","article-title":"Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors","volume":"41","author":"Dowell","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.119302_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-024-01082-w","article-title":"Pharmacodynamics and biodistribution of [195mPt]cisplatin (CISSPECT\u00ae) in head and neck squamous cell carcinoma","volume":"14","author":"de Roest","year":"2024","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ejmech.2026.119302_bib18","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1039\/D1DT00214G","article-title":"Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine","volume":"50","author":"Harringer","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2026.119302_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118216","article-title":"Repurposing carboplatin-based Pt(IV)-deferoxamine conjugates for infection theranostics","volume":"301","author":"Kraihammer","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib20","doi-asserted-by":"crossref","first-page":"20745","DOI":"10.1021\/acs.inorgchem.3c02245","article-title":"Radiometal-labeled photoactivatable Pt(IV) anticancer complex for Theranostic phototherapy","volume":"62","author":"Imberti","year":"2023","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib21","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/acs.bioconjchem.7b00378","article-title":"Synthesis, radiolabeling, and characterization of plasma protein-binding ligands: potential tools for modulation of the pharmacokinetic properties of (radio)Pharmaceuticals","volume":"28","author":"M\u00fcller","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib22","series-title":"Dosage Form Design Considerations","first-page":"371","article-title":"Protein and tissue binding: implication on pharmacokinetic parameters","author":"Deb","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119302_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ica.2012.01.028","article-title":"Understanding how the platinum anticancer drug carboplatin works: from the bottle to the cell","volume":"389","author":"Di Pasqua","year":"2012","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejmech.2026.119302_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1567216","article-title":"TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression","volume":"15","author":"Ren","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119302_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10534-020-00243-3","article-title":"Iron chelators in cancer therapy","volume":"33","author":"Ibrahim","year":"2020","journal-title":"Biometals"},{"key":"10.1016\/j.ejmech.2026.119302_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2967\/jnumed.112.115527","article-title":"Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models","volume":"54","author":"Campanile","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.119302_bib27","article-title":"Bone tumor-targeted delivery of theranostic 195mPt-bisphosphonate complexes promotes killing of metastatic tumor cells","volume":"9","author":"Nadar","year":"2021","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejmech.2026.119302_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-022-00237-6","article-title":"Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma","volume":"11","author":"Liu","year":"2023","journal-title":"Bone Res."},{"key":"10.1016\/j.ejmech.2026.119302_bib29","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1021\/acs.inorgchem.0c00445","article-title":"Multiaction Pt(IV) carbamate complexes can codeliver Pt(II) drugs and amine containing bioactive molecules","volume":"59","author":"Babu","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/jm00373a009","article-title":"Synthesis, characterization and properties of a group of Pt(IV) complexes","volume":"27","author":"Brandon","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119302_bib31","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2026.119302_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2967\/jnumed.124.268799","article-title":"RadioFlow cytometry reveals that [18F]FDG uptake in K-RAS lung cancer is driven by immune cells: an analysis on a single-cell level","volume":"66","author":"Vraka","year":"2025","journal-title":"J. Nucl. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:19:27Z","timestamp":1792642767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S0223523426007476"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119302","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of 68Ga-labelled Pt(IV)-DFO complexes as PET-imaging agents for osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119302"}}